Skip to main contentSkip to footer

STERIS announces new ethylene oxide and x-ray processing facilities in europe

December 4, 2020

As part of our long-term commitment to supporting medical device manufacturing, STERIS is pleased to announce the construction of two new processing locations in Europe.

A new ethylene oxide (EO) facility is being built in the Czech Republic, which will complement the services offered at our existing EO site in Velka Bites. In Germany, a new X-ray radiation processing site is being constructed to support our existing electron beam and gamma processing sites in Allershausen, Bitterfeld, and Radeberg.

These expansions in the Czech Republic and Germany further our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future.

Increased demand in medical device manufacturing has accelerated our plans for global expansion. The addition of radiation-processing options throughout our global network allows us to support Customers with both routine services and processing redundancy.

czech-and-germany-expansion

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. 

For more information, visit www.steris.com.

 
Related Posts
2026.04 Chester, NY Announcement (1)
June 26, 2026
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completed expansion of its existing Chester, New York radiation processing campus to include X-ray processing.
STERIS Cleanroom
June 8, 2026
As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory has expanded its sterility cleanroom, tripling the cleanroom footprint and doubling the testing capacity.
Cytotoxicity Testing
June 1, 2026
As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota laboratory now offers cytotoxicity testing services in accordance with Good Laboratory Practice (GLP).
April 1, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the completed expansion of its existing Kuala Ketil, Malaysia laboratory.